| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | 25.19▲ | 25.19▲ |
| MA10 | N/A | N/A | N/A | 25.17▲ | N/A |
| MA20 | N/A | N/A | N/A | 25.16▲ | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | -0.002▼ | N/A |
| RSI | N/A | N/A | N/A | 65.798▲ | N/A |
| STOCH | N/A | N/A | N/A | 36.165 | N/A |
| WILL %R | N/A | N/A | N/A | -33.333 | N/A |
| CCI | N/A | N/A | N/A | 161.351▲ | N/A |
| CDL | $ABI Doji Candlestick Pattern Detected | Set Alert |
|
Monday, July 21, 2025 04:59 AM
About ABI Research's Innovation Rankings ABI Research's 2025 rankings provide a rigorous, independent assessment of innovation leadership across seven technology domains.
|
|
Monday, June 30, 2025 05:00 AM
About ABI-1179-101 ABI-1179-101 is a randomized, blinded, placebo-controlled Phase 1a/b clinical study of ABI-1179.
|
|
Wednesday, February 26, 2025 06:52 AM
Assembly Biosciences Initiates Phase 1a Study Of ABI-6250, Oral Entry Inhibitor For February 26, 2025 — 09:52 am EST Written by RTTNews.com for RTTNews -> ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/08/25 | 25.22 | 25.22 | 25.22 | 25.22 | 163 |
| 22/08/25 | 25.205 | 25.205 | 25.205 | 25.205 | 1 |
| 21/08/25 | 25.16 | 25.16 | 25.16 | 25.16 | 100 |
| 20/08/25 | 25.18 | 25.18 | 25.18 | 25.18 | 53 |
| 19/08/25 | 25.17 | 25.17 | 25.17 | 25.17 | 80 |
| 18/08/25 | 25.18 | 25.27 | 25.17 | 25.17 | 3,611 |
| 15/08/25 | 25.16 | 25.16 | 25.16 | 25.16 | 100 |
| 14/08/25 | 25.15 | 25.15 | 25.15 | 25.15 | 200 |
| 13/08/25 | 25.17 | 25.17 | 25.17 | 25.17 | 100 |
| 12/08/25 | 25.15 | 25.15 | 25.15 | 25.15 | 200,187 |
|
|
||||
|
|
||||
|
|